1
Return

Continuous Dual Glucose–Ketone Sensing Technology

delete2025-11-21
delete0
PRE
AI
U
Udo Hoss *
S
Shridhara Alva
H
Heather Pryor
B
Benjamin Feldman
DOI:10.1177/15209156251390820delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Diabetic ketoacidosis (DKA) is a serious, life-threatening complication of diabetes. Although individuals who are at risk for DKA are advised to monitor ketone levels, adherence to monitoring is suboptimal. Continuous ketone monitoring is an emerging technology with the potential to address many of the limitations of current monitoring methods. Abbott Diabetes Care (Alameda, CA) has developed a continuous dual glucose–ketone sensor that measures both interstitial glucose and ketone levels simultaneously, transmitting the information in a continuous stream of data to users. However, one of the challenges in this effort was developing a sensor that can be factory-calibrated to ensure accuracy, safety, and user convenience. This article describes processes realizing factory calibration for the ketone sensor component.

Journal

Diabetes Technology and Therapeutics cover
Diabetes Technology and Therapeutics
IF:
6.3
Papers:
2.9K
Citations:
7.5K

Organization

A
abbott diabetes care, witney, united kingdom.
Scholars:
2
Papers: 1
Citations: 0
A
abbott diabetes care, alameda, california, usa.
Scholars:
5
Papers: 2
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers